GenomOncology announced that their Precision Oncology Platform now integrates patients' prior intervention eligibility criteria to further advance their treatment matching algorithm and decision support...
Bausch Health Companies Inc. announced an update on its previously stated plan to pursue an initial public offering (IPO) of its Solta Medical business...
Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value...
Nordic Bioscience, a growing biomarker company, announced the strengthening of its ongoing collaboration with Roche Diagnostics for the development of proprietary biomarkers involved in...
